Article Details

Adrenomed set to start pivotal trail in Sepsis - European Biotechnology

Retrieved on: 2022-10-18 20:26:18

Tags for this article:

Click the tags to see associated articles and topics

Adrenomed set to start pivotal trail in Sepsis - European Biotechnology. View article details on HISWAI: https://european-biotechnology.com/up-to-date/latest-news/news/adrenomed-set-to-start-pivotal-trail-in-sepsis.html

Excerpt

German Adremomed AG has got a recommendation from the EMA to push its Adrenomedullin-binding antibody Adrecizumab into a pivotal Phase III study.

Article found on: european-biotechnology.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up